Our Team

Meredith Irwin, M.D.

Committee Member

Associate Chair Pediatrics
Solid Tumor Section Head, Division of Hematology-Oncology
Senior Scientist, Cell Biology Program
Hospital for Sick Children
Professor, University of Toronto

Dr. Meredith Irwin received her MD from Harvard University and completed her Pediatrics and Hematology-Oncology training at Boston Children’s Hospital and Dana-Farber Cancer Institute. During her post-doctoral fellowship with Dr. William Kaelin, a Howard Hughes investigator at Dana Farber, she published several seminal papers on the p53-related protein p73. Since 2002 Dr. Irwin has been a clinician-scientist at the Hospital for Sick Children in the Cell Biology Program. She is currently the Associate Chair of Pediatrics for Research, Solid Tumor Section head and Co-Director of the Neuroblastoma Program. Dr. Irwin’s research focuses on (1) role of p53 family proteins in apoptosis and chemotherapy sensitivity and (2) targeting neuroblastoma (NB) signaling pathways involved in survival and metastases. She has received funding from the NIH, Canadian Cancer Society Research Institute and holds a Canada Research Chair in Cancer Biology. She is also involved in the Children’s Oncology Group (COG) Neuroblastoma Committee where she is Vice Chair of Biology and is a member of the Advances in Neuroblastoma Research North American Advisory Board, and the New Approaches to Neuroblastoma Therapy (NANT) Scientific Review Committee.

Back To Our Team